Purpose: It is an established consensus that patients suffering from Severe Mental Illness (SMI) often have somatic comorbidities and a shortened life expectancy. In this study, we examine to what extent previously unknown comorbidities can be revealed if patients suffering from SMI are examined by a specialist in general medicine using the new clinical tool of Systematic Somatic Examinations of Psychiatric Patients (SSEPP).
Methods: SSEPP is a detailed, in-depth questioning and clinical evaluation performed by a specialist in General medicine. A total of 112 patients were recruited from asylums for patients suffering from chronic and severe psychiatric disorders in the Copenhagen area. Diagnosis within SMI led to 106 patients included. 6 patients had no SMI diagnosis and were excluded. Four years later, deaths in the cohort were registered.
Results: Ninety percent of examined patients were found to have previously unknown indications for medical treatment. Nine deaths occurred among the examined patients during follow-up. All deaths happened among the 29 patients identified with high expected risk of ischemic manifestation (31%, p < .0001).
Conclusions: In this study, SSEPP is shown to be capable of: Identifying previously unknown and/or undertreated somatic comorbidity in patients with SMI. Identifying the patients with the highest risk of ischemic manifestation with a score of 9 deaths/29 patients. This is statistically significant (p < .0001). This study suggests that patients with SMI in every psychiatric ward be systematically examined for somatic comorbidity by GPs especially trained with tools like SSEPP.
Keywords: SSEPP; Severe mental illness; chronic obstructive lung disease; ischemic heart disease; mortality.